High Court bars Glenmark from making anti-diabetes drugs
The Delhi High Court on Friday restrained Indian firm Glenmark Pharmaceuticals from manufacturing, marketing or selling its anti-diabetes drugs Zita and Zita-Met, saying it has "prima facie" infringed the patent of US drug major Merck Sharp and Dohme (MSD).
Mar 20, 2015, 17:34 PM IST